Eczema

Eczema is a broad clinical term describing inflammatory skin conditions characterized by erythema, scaling, vesiculation, and intense pruritus. Although often used interchangeably with atopic dermatitis, eczema encompasses multiple subtypes including nummular eczema, dyshidrotic eczema, seborrheic dermatitis, and contact-related variants. As a frequently encountered condition across age groups, eczema represents a central theme in every comprehensive Dermatology Conference, where evolving therapeutic strategies and barrier-focused care continue to advance patient outcomes. Closely associated with eczematous skin disorders, this session explores the interplay between epidermal dysfunction, immune activation, environmental triggers, and microbiome imbalance.

Rather than presenting as a uniform disease, eczema reflects a spectrum of inflammatory responses influenced by genetic susceptibility and external stressors. The session begins by examining barrier impairment mechanisms, including altered lipid composition and increased transepidermal water loss. When the protective function of the skin is compromised, allergens and irritants penetrate more easily, amplifying inflammatory cascades and worsening itch cycles.

Clinical recognition of eczema patterns is critical for appropriate intervention. Acute lesions may display oozing vesicles and crusting, while chronic cases demonstrate lichenification and thickened plaques. Accurate differentiation between subtypes influences treatment decisions and long-term management planning. Participants will review diagnostic cues that distinguish eczema from psoriasis, fungal infections, and other inflammatory dermatoses.

Therapeutic discussions focus on restoring barrier integrity alongside controlling inflammation. Topical corticosteroids, calcineurin inhibitors, and phosphodiesterase inhibitors remain core therapies, while systemic agents and biologics offer options for severe disease. Moisturization strategies, trigger avoidance, and structured flare management plans are emphasized to reduce recurrence frequency.

Psychological impact and sleep disruption are recognized as integral components of disease burden. The session highlights patient education techniques that promote adherence and empower self-management. Advances in microbiome research and targeted immune modulation continue to reshape eczema care toward more precise and sustainable solutions.

By integrating clinical insight with emerging research, this session provides dermatologists with practical tools to manage eczema effectively while addressing both physical symptoms and quality-of-life challenges.